EYPT - Eyepoint Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EYPT is currently covered by 6 analysts with an average price target of $24.89. This is a potential upside of $15.31 (485.65%) from yesterday's end of day stock price of $4.25.

Eyepoint Pharmaceuticals's activity chart (see below) currently has 61 price targets and 67 ratings on display. The stock rating distribution of EYPT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.53% with an average time for these price targets to be met of 263.15 days.

Highest price target for EYPT is $37, Lowest price target is $5, average price target is $24.89.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Aug-2026. First documented stock forecast 01-Oct-2018.

Best performing analysts who are covering EYPT - Eyepoint Pharmaceuticals:

Raghuram Selvaraju Yi Chen Daniil Gataulin Yigal Nochomovitz Lisa Walter

Currently out of the existing stock ratings of EYPT, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jan-2025

$17

$12.42 (271.18%)

$35

24 days ago
(18-Aug-2026)

0/3 (0%)

$11.53 (210.79%)

Buy Since 17-Jun-2025

$5

$0.42 (9.17%)

$37

24 days ago
(18-Aug-2026)

1/4 (25%)

$-0.47 (-8.59%)

6

Buy Since 16-Nov-2021

$27

24 days ago
(18-Aug-2026)

8/22 (36.36%)

$14.17 (110.44%)

301

Buy Since 07-Jul-2022

$5

$0.42 (9.17%)

$29

24 days ago
(18-Aug-2026)

4/11 (36.36%)

$-0.47 (-8.59%)

221

Buy Since 22-Jan-2024

$26

25 days ago
(17-Aug-2026)

0/4 (0%)

$20.04 (336.24%)

Show more analysts

Please expand the browser size to see the chart

What is EYPT (Eyepoint Pharmaceuticals) average time for price targets to be met?

On average it took 263 days for the stock forecasts to be reached, with an average price target met ratio of 32.53%.

Which analyst most recently updated their price target on EYPT (Eyepoint Pharmaceuticals)?

Yigal Nochomovitz

Which analyst has the most public recommendations on EYPT (Eyepoint Pharmaceuticals)?

Yigal Nochomovitz works at CITI and has 13 price targets and 9 ratings on EYPT

Which analyst is the currently most bullish on EYPT (Eyepoint Pharmaceuticals)?

Yale Jen with the highest potential upside of $45.42

Which analyst is the currently most reserved on EYPT (Eyepoint Pharmaceuticals)?

Dana Flanders with the lowest potential downside of -$10.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?